The UK Government’s Backing for GLP-1 Weight-Loss Medicines

The UK Government’s Backing for GLP-1 Weight-Loss Medicines

Weight loss has become a national health priority.

For the first time, the UK government is openly backing the use of GLP-1 weight-loss medicines. In public statements, Health Secretary Wes Streeting has described these treatments as a “game changer” - not just for individuals, but for the NHS and the economy.

Government support sends a powerful signal.

  • Obesity costs the NHS over £6.5 billion a year in direct healthcare costs (NHS England).
  • Wider society bears a further £27 billion in lost productivity every year (Public Health England).
  • Ministers have made it clear: supporting people to lose weight is essential for the nation’s health, wealth, and future.

This isn’t just about vanity. It’s about preventing diabetes, reducing strokes, and helping people live longer, healthier lives.

Wes Streeting Has Said  "Game-changing" 

In July 2025, Health Secretary Wes Streeting announced new NHS pilots offering GLP-1 medicines for weight loss, describing them as:

“A major step forward in tackling obesity and type 2 diabetes. These medicines can help save lives and reduce the pressure on the NHS.”

 

The NHS Rollout: Progress and Limits

While the government is backing these treatments, access through the NHS is limited:

  • Prescriptions are restricted to those meeting strict criteria.
  • Supply is capped, with waiting lists in many areas.
  • Many people who could benefit are currently excluded.

This means that although the government is behind GLP-1 medicines, most people cannot yet access them via the NHS.

Why Access Matters

Medical weight loss is about more than numbers on a scale. Evidence shows GLP-1 receptor agonists:

  • Reduce the risk of developing type 2 diabetes.
  • Improve cardiovascular outcomes.
  • Enhance quality of life by boosting mobility and energy.

For families, this can mean more time together. For the economy, fewer sick days and greater productivity. For the NHS, billions saved on avoidable hospital admissions.

Taking Responsibility for Your Own Health

The government’s backing should be motivating: the science is proven, the results are real, and the highest levels of UK leadership are on board.

But waiting for the NHS may mean waiting too long. For those who want to take action now, safe, regulated private programmes like a Forge Membership provide:

  • Digital consultations with UK-registered prescribers.
  • Repeat prescription management and resupply, so you stay compliant.
  • Sharps bins, swabs, and guidance included in your first order.
  • Support and lifestyle content to maximise results.
  • Priority access to new tools and programmes as they launch.

You don’t have to wait for NHS criteria to change. You can start today.

A Motivational Closing Thought

The Health Secretary calls these medicines a “game changer.” The government is investing because they know the evidence is clear: GLP-1s can transform lives.

The NHS may restrict access for now, but your health can’t wait.

👉 Start your journey today with Forge Membership

 

This content is for educational purposes only and is not a substitute for professional medical advice. A Forge membership does not guarantee a prescription. The decision to prescribe is made independently by a qualified prescriber in your best medical interests.

Back to blog